Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined
Código 292320 (Harmonized System 2012 by 6 digits)
2023: US$33.8M, Total Trade Exchange
2023: US$10.4M, International Sales
2023: US$23.4M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined was US$33.8M.
In 2023, the states with the most international sales in Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Estado de México (US$3.86M) and Ciudad de México (US$35.4k).
The states with the most international purchases in 2023 were Ciudad de México (US$8.79M), Estado de México (US$7.82M), Jalisco (US$3.56M), Nuevo León (US$1.12M), and Tamaulipas (US$145k).
In 2023, the main commercial destinations of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Canada (US$3.15M), United States (US$680k), Cuba (US$62.5k), Colombia (US$444), and Argentina (US$335).
The main commercial origins of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined in 2023 were United States (US$13.3M), Brazil (US$5.91M), Argentina (US$582k), India (US$555k), and Germany (US$256k).
In the global context, the main exporting countries of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined in 2022 were Germany (US$225M), Netherlands (US$210M), and India (US$195M). In the same year, the main importing countries of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Netherlands (US$252M), United States (US$129M), and Germany (US$94.5M).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionUS$33.8M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined in Mexico (including international purchases and sales) was US$33.8M.
The visualizations show the net balance of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionNovember, 2024: US$1.7M, International Purchases
In November 2024, international sales of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were US$0, while international purchases reached US$1.7M. The above results in a trade balance of -US$1.7M.
Market Concentration
#permalink to section2024-Q4: US$3.43k, International Sales
The visualization shows the quarterly concentration of international sales of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined at state level.
In the fourth quarter of 2024, international sales were US$3.43k, being the states with the most sales Ciudad de México (US$3.43k).
Exchange by Territory
#permalink to sectionInternational Sales
#permalink to sectionEstado de México: US$3.86M, State with the Most International Sales (2023)
Canada: US$3.15M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Estado de México (US$3.86M) and Ciudad de México (US$35.4k).
In 2023, the countries with the most international purchases from Mexico were Canada (US$3.15M), United States (US$680k), Cuba (US$62.5k), Colombia (US$444), and Argentina (US$335).
International Purchases
#permalink to sectionCiudad de México: US$8.79M, State with the Most International Purchases (2023)
United States: US$13.3M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Ciudad de México (US$8.79M), Estado de México (US$7.82M), Jalisco (US$3.56M), Nuevo León (US$1.12M), and Tamaulipas (US$145k).
The countries with the most international sales to Mexico in 2023 were United States (US$13.3M), Brazil (US$5.91M), Argentina (US$582k), India (US$555k), and Germany (US$256k).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0.025%, Mexican share in global exports - 2022
- 1.03%, Mexican share in global imports - 2022
The visualizations show the global market for Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Germany (US$225M), Netherlands (US$210M), and India (US$195M). In the same year, the main importing countries for Lecithins and other Phosphoaminolipids, Incl. of not Chemically Defined were Netherlands (US$252M), United States (US$129M), and Germany (US$94.5M).